|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Malignant intestinalnon-Hodgkin’lymphoma from the surgical point of view 显示文摘 | Samel S Wagner J Hofheinz R | 2002 | Onkol-ogie2002，25，3： | 1 |
| 2 | Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer显示文摘 | Boda-Heggemann J Hofheinz R D Weiss C | 2009 | Int J Radiat Oncol Biol Phys2009，75，4： | 1 |
| 3 | Capecitabine versus 5-flu- orouracil-based (neo) adjuvant chemoradiotherapy for lo- cally advanced rectal cancer: long-term results of a ran domized, phase III trial显示文摘 | Hofheinz R Wenz FK Post S | 2011 | J Clin Oncolo2011，29，11： | 1 |
| 4 | BBR3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer:a phase II study group trial of the Central European Society of Anticancer-Drug Research (CESAR) 显示文摘 | Hofheinz R D Porta C Hartung G | 2005 | Invest New Drugs2005，23，4： | 1 |
| 5 | Liposomal encapsulated anti-cancer drugs显示文摘 | HOFHEINZ R D GNAD-VOGT S U BEYER U | 2005 | Anticancer Drugs2005，16，7： | 1 |
| 6 | Perioperative ehemo(radio) therapy versus primary surgery for reseetable adenocar- einoma of the stomach, gastroesophageal junction, and lower esophagus 显示文摘 | Ronellenfitsch U Sehwarzbaeh M Hofheinz R | 2013 | The Coehrane database of systematic reviews2013，，08： | 1 |
| 7 | Liposomal encapsulatedanti-cancer drugs显示文摘 | Hofheinz R D Gnad-Vogt S U Beyer U | 2005 | Anticancer Drugs2005，16，7： | 1 |
| 8 | A practical attack on some braid group based cryptographic primitives 显示文摘 | Hofheinz D Steinwandt R | 2002 | Lectare Notes in Computer Science2002，2567，： | 1 |
| 9 | Rectal cancer:state of the art in 2012显示文摘 | RODEL C HOFHEINZ R LIERSCH T | 2012 | Curr Opin Oncol2012，24，4： | 1 |
| 10 | Malignant intestinal nonHodgkin's lymphoma from the surgical point of view显示文摘 | Samel S Wagner J Hofheinz R | 2002 | Onkologie2002，25，3： | 1 |
| 11 | 查看详情显示文摘 | Hofheinz M Weig E M Ansmann M Bialczak R C Lucero E Neeley M O'Connell A D Wang H Martinis J M Cleland A N | | 0，，： | 1 |
| 12 | Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term resuhs of a randomized, phase III trial 显示文摘 | Hofheinz R Wenz FK Post S | 2011 | J Clin Oncol2011，29，15： | 1 |
| 13 | Adding weekly irino- teean to high-dose fluorouracil and folinic acid (HD-5-FU/FA) after failure for first-line HD-5-FU/FA in advanced colorectal cancer- a phase Ⅱ study显示文摘 | Hofheinz R Hartung G Samel S el al | 2002 | Anti-cancer Drugs2002，，99： | 1 |
| 14 | Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer:results of a phase Ⅱ trial显示文摘 | Gnad-Vogt S U Hofheinz R D Saussele S | 2005 | Anticancer Drugs2005，16，4： | 1 |
| 15 | Biweekly fluorouracil,leucovorin,oxaliplatin,and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction:a phase Ⅱ trial of the Arbeitsgemeinschaft Internistische Onkologie显示文摘 | Al-Batran SE Hartmann JT Hofheinz R | 2008 | Ann Oncol2008，19，11： | 1 |
| 16 | Expression of transketolase like gene 1 ( TKTL1 ) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy 显示文摘 | Schwaab J Hofmann W Hofheinz R | 2011 | BMC Cancer2011，11，1： | 1 |
| 17 | Malignant intestinal non-Hodgkin's lymphoma from the surgical point of view显示文摘 | Samel S Wagner J Hofheinz R | 2005 | Onkologie2005，25，3： | 1 |
| 18 | Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer : a randomised, muhicentre, non - inferiority, phase 3 trial 显示文摘 | HOFHEINZ R D WENZ F POST S | 2012 | Lancet Oncol2012，13，6： | 1 |
| 19 | Rectal cancer: state of the art in 2012 显示文摘 | Rodel C Hofheinz R and Liersch T | 2012 | Curt Opin Oncol2012，24，4： | 1 |
| 20 | Rectal cancer: state of the art in 2012显示文摘 | Rodel C Hofheinz R Liersch T | 2012 | Curr Opin Oneol2012，24，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员